Increasing the Use of Self Measured Home Blood Pressure Logs in the Management of Hypertension
Public ClinicalTrials.gov record NCT07556783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Telephone-Based Patient Outreach to Improve Self-Measured Blood Pressure Log Utilization in Chronic Hypertension: A Pragmatic Quality Improvement Randomized Implementation Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The Telephone-Based Patient Outreach to Improve Home Blood Pressure Monitoring (HBPM) in Chronic Hypertension study is a pragmatic, randomized, open-label quality improvement implementation trial designed to evaluate the effectiveness of a structured telephone outreach intervention in increasing the proportion of patients with chronic hypertension who present to clinic visits with a completed home blood pressure log compared to the receipt of usual primary care services over a 90-day period. The study aims to address the inconsistent integration of HBPM-an evidence-based strategy endorsed by major guidelines to improve diagnostic accuracy and longitudinal management-into routine primary care workflows where no standardized educational or documentation process currently exists. Patients with documented chronic uncontrolled hypertension, defined as three documented readings exceeding 130/80 mmHg, are eligible for participation. Typically, patients at this academic primary care practice lack a standardized process for receiving education on home monitoring or a dedicated mechanism for documenting logs, which can lead to therapeutic inertia and missed opportunities to optimize treatment. The intervention is designed around a structured telephone outreach program led by medical students using a standardized script to provide direct patient education on the clinical value of HBPM and to encourage the completion and presentation of BP logs during subsequent primary care visits.
Study identification
- NCT ID
- NCT07556783
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 170 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 18, 2025
- Primary completion
- Apr 7, 2026
- Completion
- Apr 7, 2026
- Last update posted
- Apr 28, 2026
2025 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AdventHealth Winter Park | Orlando | Florida | 32792 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07556783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 28, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07556783 live on ClinicalTrials.gov.